Indian Pharma Network – Buy Prescriptions Drugs

18008891064
info@indianpharmanetwork.in

Facebook Twitter Linkedin Whatsapp

logo_pharma

Menu

Home
About Us
Product List
Blog
Support & FAQs
News
Contact Us

Search

Close

All Posts By

Nitin Goswami

acute lymphocytic leukemia

Atriance: Navigating the Landscape of T-Cell Disorders with Precision

News

FDA Approves Padcev with Pembrolizumab for Urothelial Cancer

News

FDA Updates Kineret Label for Emergency Use in COVID-19 Treatment

News

FDA approval of Trodelvy: HR-positive breast cancer treatment

multiple Myeloma

First SLAMF7 Antibody Therapy for Previously Treated Multiple Myeloma

News

FDA approval for Colorectal cancer & small lymphocytic lymphoma Treatment

CML

Ponatinib Shines as Induction Therapy in Chronic Phase CML

Brain Metastasis Breast Cancer

Tukysa regimen: Advancing metastatic breast cancer

News

A New Medicine in the Town for Rare Hereditary Disorder: Epidermolysis Bullosa

ALL

Blincyto Revolutionizing Relapsed ALL Treatment

Previous 1 … 14 15 16 17 18 … 24 Next

Related Posts

Understanding Rheumatoid Arthritis (RA)

Key Takeaways: Rheumatoid arthritis (RA)...

Neonatal Onset Multisystem Inflammatory...

Neonatal-onset multisystem Inflammatory Disease (NOMID)...

Cryopyrin-Associated Periodic Syndromes (CAPS)...

Cryopyrin-Associated Periodic Syndromes (CAPS) comprise...

trastuzumab injection

FDA Approves New Treatment...

The United States Food and...

Physiotherapy for rheumatoid arthritis

Rheumatoid arthritis (RA) is more...

Recent Posts

Cystinosis: Symptoms, Types, Treatment Options, and Long-Term Outlook
Primary IGF-1 Deficiency Treatment in India: Symptoms, Diagnosis & Cost of Therapy
Elahere Price in India: Availability, Import Process, and How to Buy Elahere in India
DMD Treatment in India: What Should Patients and Families Know?
Trientine Hydrochloride: Uses, Safety, and Patient Care

Indian Pharma Network helps in accessing new products in India. These products are launched and approved recently in USA or Europe but yet to be approved in India. We help in accessing these new launches through named patient import

INDIA PHARMA NETWORK

Home
About Us
News
Blog
Contact Us

TOP IMPORTED MEDICINES

Trodelvy in India
Braftovi in India
Tukysa in India
Blincyto in India
Tibsovo in India
Padcev in India

Kineret in India
Retevmo in India
Soliris in India
Zavesca in India
Zelboraf in India

CORPORATE OFFICE

Indian Pharma Network.
905-9th Floor, I-Thum Business Park,
Tower A, Plot no. A-40, Unit no. 5,
Sector-62, Noida 201301,
info@indianpharmanetwork.in

GET IN TOUCH

Indian Pharma Network facilitates patients connecting with genuine pharmaceutical suppliers, wholesalers and dealers.

Facebook Whatsapp Twitter Linkedin Pinterest

IMPORTED MEDICINES

Trodelvy in India
Braftovi in India
Tukysa in India
Blincyto in India
Tibsovo in India
Padcev in India

Kineret in India
Retevmo in India
Soliris in India
Zavesca in India
Zelboraf in India
Polivy in India

BEST TREATMENT

Muscular Dystrophy
Bladder Cancer
Brain Tumor
Cervical Cancer
Prostate Cancer
Breast Cancer

Rheumatoid Arthritis
Lung Cancer
Ovarian Cancer
Acute Myeloid Leukemia
Thyroid cancer
Kidney cancer

TOP ARTICLES

Eculizumab
HMPV
aHUS
PNH
Melanoma
PAH

PBC
MPOX Virus
Counterfeit Drugs
Nelarabine Injections
Polivy
Trodelvy

FDA DRUG APPROVALS 2025

Journavx
symbravo
Grafapex
Romvimza
Alhemo

Datroway
Brynovin
Gomekli
Alyftrek
Tryngolza

IMPORTED MEDICINES

Trodelvy in India
Braftovi in India
Trientine in India
Blincyto in India
vyloy in India
Orencia in India
Welireg in India

Kineret in India
Retevmo in India
Lazcluze in india
Trientine Availability
Imdeltra In India
Krazati in India
Lytgobi in India

BEST TREATMENT

Muscular Dystrophy
Bladder Cancer
Brain Tumor
Cervical Cancer
Prostate Cancer
Breast Cancer
Colorectal Cancer
Wilson’s Disease

Rheumatoid Arthritis
Lung Cancer
Ovarian Cancer
Acute Myeloid Leukemia
Thyroid cancer
Kidney cancer
Duchenne Muscular Dystrophy

TOP ARTICLES

Eculizumab
HMPV
aHUS
PNH
Melanoma
PAH
Trodelvy

PBC
MPOX Virus
Counterfeit Drugs
Nelarabine
Polivy

FDA Drug Approvals

Lumakras
Gavreto
symbravo
Grafapex
Romvimza
Alhemo
Zepzelca
Agilus

Datroway
Brynovin
Gomekli
Alyftrek
Tryngolza
Columvi
Rinvoq
Lazcluze

Latest News

Trusted Global Supplier from India
Takeda’s Qdenga Vaccine
Manufacture Risdiplam for (SMA)
FDA Approves Qfitlia (Fitusiran) for Hemophilia
Wilson’s Disease: Neurological Symptoms, Early Signs, and Treatment Options

Indian Pharma Network

Indian Pharma Network Tower A 905, I-Thum Business Park, Block A, Sector 62, Noida, Uttar Pradesh 201301

Mission Vision and value

Mobile/WhatsApp/Phone

M: +91 9654860915
M: +91 9310090915

Free Customer Support

info@indianpharmanetwork.in

Disclaimer : Website: indianpharmanetwork.in is a pharmaceutical trading entity that procures and supplies prescribed medicines strictly from manufacturers or duly authorized distributors. The company does not manufacture, formulate, or alter any pharmaceutical products. All trademarks, brand names, and product names referenced remain the property of their respective owners. Any use of such names is solely for identification purposes and is in compliance with the provisions of the Trademark Act, 1999, including principles of fair use. Website: indianpharmanetwork.in does not claim ownership of, nor does it assert any rights over, any patents associated with the products supplied. Compliance with patent laws, including the Patents Act, 1970, rests with the respective patent holders, manufacturers, or marketing authorization holders. The company facilitates access to certain medicines, including new launches, through legally permissible channels such as named patient import, strictly against valid prescriptions and in accordance with applicable laws and regulatory requirements. Nothing herein shall be construed as an inducement or authorization to infringe any intellectual property rights.

© 2026 Indian Pharma Network - Buy Prescriptions Drugs.

How can I Help You?

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.